Parker Waichman LLP

FDA Requires Black Box Warning to be Added to Uloric

As reported online in a news article from thepharmaletter.com, the U.S. Food and Drug Administration has ordered a Black Box warning to be placed on a popular drug prescribed for gout. The warning is associated with newly surfaced information indicating that the drug Uloric is associated with an increased risk of death. For several months, […]

Fda requires black box warning to be added to uloric

Gout condition in toe

As reported online in a news article from thepharmaletter.com, the U.S. Food and Drug Administration has ordered a Black Box warning to be placed on a popular drug prescribed for gout. The warning is associated with newly surfaced information indicating that the drug Uloric is associated with an increased risk of death.

For several months, the FDA has been conducting an investigation into the safety risks of the gout drug Uloric (febuxostat). This investigation is now closing with the requirement that the manufacturer place a strong boxed warning on the drug label. The FDA is also implementing a requirement that use of the drug be limited only to patients who have not received therapeutic benefit from another gout drug called Zyloprim (allopurinol).

The Black Box warning for the drug Uloric and its generic counterpart will need to include information stating that the drug is linked to increased risk of death from cardiovascular problems and increased risk of death from all other causes. The FDA has also ordered a new patient guide for the drug that outlines the updated risks and benefits of taking the medication.

Uloric has been on the market since 2009 when it was approved for treatment of gout and the symptoms of gout. The manufacturer of the drug is Takeda Pharmaceuticals. From the point of approval, the drug label for Uloric has stated the medication is linked to increased risk of gout flares and to cardiovascular events, as well as hepatic toxicity and dermatological complications.

Upon receipt of information gathered in a post-market study on Uloric, the advisory panel of the FDA convened in January 2019 to discuss the health risks of the drug and whether the drug should be pulled from the market. The panel voted at that time to maintain the drug’s availability, finding that the benefits still outweighed the potential health complications to patients. However, the majority of the panel also agreed that Uloric should be used as a backup for most patients who have gout.

Takeda will now have to update its drug label for Uloric to reflect the requirements from the FDA and will need to generate a new Medication Guide for patients to review when their doctors prescribe Uloric. Updates to the generic version of the drug will then follow. For more information about recovering compensation, please read our Uloric Gout Treatment Side Effects Causes Heart Attacks and Death Lawsuit page.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Joseph Cento
6 years ago
5 Star Reviews 150
very good
ronald hernandez
7 years ago
5 Star Reviews 150
I had a wonderful experience dealing with Parker Waichman LLP. Michelle Josama carefully took me through the process and handle my case with speed and Accuracy. Thank you for a everything.
mark mitchell
3 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038